Skip to main content

Advertisement

Log in

Gastroenteropancreatic neuroendocrine neoplasm imaging: standard reporting templates

  • Special Section: Neuroendocrine Neoplasms
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

Standardized reporting in radiology has an established role in numerous disease processes, with added benefits in oncology of reduced variability, and generation of a thorough and pertinent report with a focused and relevant conclusion. Many radiologists are not familiar with the imaging patterns of neuroendocrine neoplasm (NEN) spread and recurrence. This paper will present standardized CT, MRI, and PET templates for reporting gastroenteropancreatic (GEP) NENs and explain the rationale for including specific pertinent positive and negative findings, at various stages of disease management, based on site of origin.

Methods

Basic templates for initial and follow-up anatomic and molecular GEP NEN imaging were created with input from the multidisciplinary Society of Abdominal Radiology (SAR) Neuroendocrine Tumor Disease Focused Panel (NET-DFP). The templates were further modified and finalized after several iterations.

Results

Four main report templates were generated for (i) initial anatomic CT or MR imaging studies, (ii) follow-up anatomic CT or MR imaging studies, (iii) initial Somatostatin Receptor (SSTR) or FDG PET imaging studies, and (iv) follow-up SSTR or FDG PET imaging studies. Each study template was formatted to allow its integration into a dictation software directly and be modified as needed, with internalized instructions indicating where a drop-down menu or macro may be used to personalize the template as necessary.

Conclusion

These templates were created through a combination of multidisciplinary expert opinion discussion supported by literature review and provide basic structured reporting standards for GEP NEN anatomic and molecular imaging studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Xu Z, Wang L, Dai S, Chen M, Li F, Sun J, et al. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States. JAMA Network Open. 2021;4:e2124750–e2124750. doi:https://doi.org/10.1001/jamanetworkopen.2021.24750

    Article  PubMed  PubMed Central  Google Scholar 

  2. Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol. 2017;3:1335–42. doi:https://doi.org/10.1001/jamaoncol.2017.0589

    Article  PubMed  PubMed Central  Google Scholar 

  3. Chan DL, Pavlakis N, Schembri GP, Bernard EJ, Hsiao E, Hayes A, et al. Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance. Theranostics. Ivyspring International Publisher; 2017;7:1149–58. doi: https://doi.org/10.7150/thno.18068

    Article  CAS  Google Scholar 

  4. Brook OR, Brook A, Vollmer CM, Kent TS, Sanchez N, Pedrosa I. Structured reporting of multiphasic CT for pancreatic cancer: potential effect on staging and surgical planning. Radiology. United States; 2015;274:464–72. DOI: https://doi.org/10.1148/radiol.14140206

    Article  Google Scholar 

  5. Dimarco M, Cannella R, Pellegrino S, Iadicola D, Tutino R, Allegra F, et al. Impact of structured report on the quality of preoperative CT staging of pancreatic ductal adenocarcinoma: assessment of intra- and inter-reader variability. Abdom Radiol (NY). United States; 2020;45:437–48. https://doi.org/10.1007/s00261-019-02287-7

  6. Hicks RJ, Dromain C, de Herder WW, Costa FP, Deroose CM, Frilling A, et al. ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. J Neuroendocrinol. United States; 2022;34:e13040. DOI: https://doi.org/10.1111/jne.13040

  7. Dromain C, Vullierme M-P, Hicks RJ, Prasad V, O’Toole D, de Herder WW, et al. ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours. Journal of Neuroendocrinology. John Wiley & Sons, Ltd; 2022;34:e13044. DOI: https://doi.org/10.1111/jne.13044

  8. Kahn CEJ, Langlotz CP, Burnside ES, Carrino JA, Channin DS, Hovsepian DM, et al. Toward best practices in radiology reporting. Radiology. United States; 2009;252:852–6. DOI: https://doi.org/10.1148/radiol.2523081992

    Article  Google Scholar 

  9. Galgano SJ, Iravani A, Bodei L, El-Haddad G, Hofman MS, Kong G. Imaging of Neuroendocrine Neoplasms: Monitoring Treatment Response-AJR Expert Panel Narrative Review. AJR Am J Roentgenol. United States; 2022;1–14. DOI: https://doi.org/10.2214/AJR.21.27159

  10. Krenning E, Valkema R, Kooij P, Breeman W, Bakker W, deHerder W, et al. Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide. Ital J Gastroenterol Hepatol. 1999;31 Suppl 2:S219-23.

    PubMed  Google Scholar 

  11. Werner RA, Solnes L, Javadi M, Weich A, Gorin M, Pienta K, et al. SSTR-RADS Version 1.0 as a Reporting System for SSTR-PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework. J Nucl Med. 2018;jnumed.117.206631. DOI: https://doi.org/10.2967/jnumed.117.206631

  12. Kratochwil C, Stefanova M, Mavriopoulou E, Holland-Letz T, Dimitrakopoulou-Strauss A, Afshar-Oromieh A, et al. SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors. Mol Imaging Biol. United States; 2015;17:313–8. DOI: https://doi.org/https://doi.org/10.1007/s11307-014-0795-3

    Article  CAS  Google Scholar 

  13. Metser U, Eshet Y, Ortega C, Veit-Haibach P, Liu A, K S Wong R. The association between lesion tracer uptake on 68Ga-DOTATATE PET with morphological response to 177Lu-DOTATATE therapy in patients with progressive metastatic neuroendocrine tumors. Nucl Med Commun. England; 2022;43:73–7. Doi: https://doi.org/10.1097/MNM.0000000000001488

  14. Binderup T, Knigge U, Loft A, Federspiel B, Kjaer A. 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors. Clin Cancer Res. United States; 2010;16:978–85. DOI: https://doi.org/https://doi.org/10.1158/1078-0432.CCR-09-1759

    Article  CAS  Google Scholar 

  15. Ganeshan D, Duong P-AT, Probyn L, Lenchik L, McArthur TA, Retrouvey M, et al. Structured Reporting in Radiology. Acad Radiol. United States; 2018;25:66–73. DOI: https://doi.org/10.1016/j.acra.2017.08.005

Download references

Acknowledgements

We thank all members of the Society of Abdominal Radiology (SAR) Neuroendocrine Tumor Disease Focused Panel (NET-DFP) for refining the templates.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chadwick Barrs.

Ethics declarations

Conflict of interests

Authors have no relevant financial disclosures.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 33 KB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barrs, C., Itani, M., Zulfiqar, M. et al. Gastroenteropancreatic neuroendocrine neoplasm imaging: standard reporting templates. Abdom Radiol 47, 3986–3992 (2022). https://doi.org/10.1007/s00261-022-03677-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-022-03677-0

Keywords

Navigation